These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21704607)

  • 1. Persistent elevation of paraoxonase-1 specific enzyme activity after weight reduction in obese non-diabetic men with metabolic syndrome.
    Liang KW; Lee WJ; Lee IT; Lee WL; Lin SY; Hsu SL; Wan CJ; Yu CY; Tsai IC; Fu CP; Ting CT; Sheu WH
    Clin Chim Acta; 2011 Sep; 412(19-20):1835-41. PubMed ID: 21704607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome.
    Ferré N; Feliu A; García-Heredia A; Marsillach J; París N; Zaragoza-Jordana M; Mackness B; Mackness M; Escribano J; Closa-Monasterolo R; Joven J; Camps J
    Clin Biochem; 2013 Dec; 46(18):1830-6. PubMed ID: 24028901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofibrate increases paraoxonase activity in patients with metabolic syndrome.
    Paragh G; Seres I; Harangi M; Erdei A; Audikovszky M; Debreczeni L; Kovácsay A; Illyés L; Pados G
    Br J Clin Pharmacol; 2006 Jun; 61(6):694-701. PubMed ID: 16722831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- and long-term relationships of serum ghrelin with changes in body composition and the metabolic syndrome in prepubescent obese children following two different weight loss programmes.
    Kelishadi R; Hashemipour M; Mohammadifard N; Alikhassy H; Adeli K
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):721-9. PubMed ID: 18284632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender related differences in paraoxonase 1 response to high-fat diet-induced oxidative stress.
    Thomàs-Moyà E; Gómez-Pérez Y; Fiol M; Gianotti M; Lladó I; Proenza AM
    Obesity (Silver Spring); 2008 Oct; 16(10):2232-8. PubMed ID: 18719679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight loss reduces serum monocyte chemoattractant protein-1 concentrations in association with improvements in renal injury in obese men with metabolic syndrome.
    Fu CP; Sheu WH; Lee IT; Lee WJ; Wang JS; Liang KW; Lee WL; Lin SY
    Clin Chem Lab Med; 2015 Mar; 53(4):623-9. PubMed ID: 25301674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the presence of metabolic syndome influence weight loss in obese and overweight women?
    Evangelou P; Tzotzas T; Christou G; Elisaf MS; Kiortsis DN
    Metab Syndr Relat Disord; 2010 Apr; 8(2):173-8. PubMed ID: 20156072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight loss improves heart rate recovery in overweight and obese men with features of the metabolic syndrome.
    Brinkworth GD; Noakes M; Buckley JD; Clifton PM
    Am Heart J; 2006 Oct; 152(4):693.e1-6. PubMed ID: 16996838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
    Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS
    Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals.
    Bajnok L; Seres I; Varga Z; Jeges S; Peti A; Karanyi Z; Juhasz A; Csongradi E; Mezosi E; Nagy EV; Paragh G
    Metabolism; 2007 Nov; 56(11):1542-9. PubMed ID: 17950106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orlistat increases serum paraoxonase activity in obese patients.
    Audikovszky M; Pados G; Seres I; Harangi M; Fülöp P; Katona E; Illyés L; Winkler G; Katona EM; Paragh G
    Nutr Metab Cardiovasc Dis; 2007 May; 17(4):268-73. PubMed ID: 17134960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of weight loss on cortisol secretion in obese men with and without metabolic syndrome features.
    Parra MD; Martínez de Morentin BE; Alfredo Martínez J
    Nutr Metab Cardiovasc Dis; 2006 Jan; 16(1):28-34. PubMed ID: 16399489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The obesity paradox, weight loss, and coronary disease.
    Lavie CJ; Milani RV; Artham SM; Patel DA; Ventura HO
    Am J Med; 2009 Dec; 122(12):1106-14. PubMed ID: 19682667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome.
    Chan DC; Watts GF; Ng TW; Yamashita S; Barrett PH
    Eur J Clin Invest; 2008 Oct; 38(10):743-51. PubMed ID: 18837799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum paraoxonase 1 activity in women with metabolic syndrome.
    Yilmaz H; Sayar N; Yilmaz M; Gurkan U; Sesal C; Tosu R; Cakmak N; Erer B; Oz D; Ciloglu F; Bolca O
    Kardiol Pol; 2010 Nov; 68(11):1219-24. PubMed ID: 21108196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of adiponectin, orexin-A, ghrelin and the antioxidant paraoxonase-1 in metabolic syndrome.
    Tabak O; Gelişgen R; Cicekçi H; Senateş E; Erdenen F; Müderrisoğlu C; Aral H; Uzun H
    Minerva Med; 2012 Aug; 103(4):323-9. PubMed ID: 22805624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
    J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight loss increased serum adiponectin but decreased lipid levels in obese subjects whose body mass index was lower than 30 kg/m².
    Lang HF; Chou CY; Sheu WH; Lin JY
    Nutr Res; 2011 May; 31(5):378-86. PubMed ID: 21636016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.
    Arnlöv J; Ingelsson E; Sundström J; Lind L
    Circulation; 2010 Jan; 121(2):230-6. PubMed ID: 20038741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome.
    Niskanen L; Laaksonen DE; Punnonen K; Mustajoki P; Kaukua J; Rissanen A
    Diabetes Obes Metab; 2004 May; 6(3):208-15. PubMed ID: 15056129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.